about
Large-scale data integration framework provides a comprehensive view on glioblastoma multiformeThe Genetic Landscape of Renal Complications in Type 1 Diabetes.ErbB2-driven breast cancer cell invasion depends on a complex signaling network activating myeloid zinc finger-1-dependent cathepsin B expression.Rituximab regulates signaling pathways and alters gene expression associated with cell death and survival in diffuse large B-cell lymphoma.Posttranscriptional regulation of angiotensin II type 1 receptor expression by glyceraldehyde 3-phosphate dehydrogenase.Signal transducers and activators of transcription 5a-dependent cross-talk between follicular lymphoma cells and tumor microenvironment characterizes a group of patients with improved outcome after R-CHOP.Identification of a c-Jun N-terminal kinase-2-dependent signal amplification cascade that regulates c-Myc levels in ras transformation.A Genome-Wide Association Study of Diabetic Kidney Disease in Subjects With Type 2 Diabetes.Early Trichinella spiralis and Trichinella nativa infections induce similar gene expression profiles in rat jejunal mucosaConfirmation of GLRA3 as a susceptibility locus for albuminuria in Finnish patients with type 1 diabetesGenetic Determinants of Glycated Hemoglobin in Type 1 DiabetesGenome-Wide Association Study of Diabetic Kidney Disease Highlights Biology Involved in Glomerular Basement Membrane CollagenWhole-Genome Sequencing of Finnish Type 1 Diabetic Siblings Discordant for Kidney Disease Reveals DNA Variants associated with Diabetic NephropathyBiomarker panels associated with progression of renal disease in type 1 diabetesVariations in Risk of End-Stage Renal Disease and Risk of Mortality in an International Study of Patients With Type 1 Diabetes and Advanced Nephropathy
P50
Q21183973-CC81887A-4136-4DD7-8CE3-D3698E0FD0D3Q30275890-DA233327-8AAC-4EAB-9C6F-D773ECB3BFCBQ39371752-5D346CC3-41FF-4796-82C4-B8C1FD498D4BQ39783293-0E1F422B-3B9F-4E50-AD5C-1E8D6B1F9839Q39879276-0657E6B3-7217-4052-B301-4451CCD84CA1Q43100951-E2CD0767-C207-4745-8A60-C95FB56529DEQ44938943-F2DA063A-8E09-488C-884F-B0906FB85BF8Q52804042-51615227-E51C-46DD-9E25-813B3946F026Q57112311-208372E8-7072-4D08-A6B4-1ACC1264F4E6Q57606405-CF9DC978-04F2-46C9-9446-A08B0C381A2BQ63869351-B7F17988-12B2-4145-88BD-E4564C4BAB67Q90182401-55B36D0B-81D7-4022-B242-EE81F594DF0EQ92525583-F776FA2D-24A3-4A22-9479-9AB56ED56A92Q92922094-73ED2B54-9606-4346-9005-48C0A32C6DA8Q93222242-27491A5D-3DA0-4D9A-A312-E1247A172EDD
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Erkka Valo
@ast
Erkka Valo
@en
Erkka Valo
@es
Erkka Valo
@nl
Erkka Valo
@sl
type
label
Erkka Valo
@ast
Erkka Valo
@en
Erkka Valo
@es
Erkka Valo
@nl
Erkka Valo
@sl
prefLabel
Erkka Valo
@ast
Erkka Valo
@en
Erkka Valo
@es
Erkka Valo
@nl
Erkka Valo
@sl
P106
P31
P496
0000-0003-0672-554X